| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-06-15 18:04:00 UTC |
|---|
| Update Date | 2021-09-14 15:42:08 UTC |
|---|
| HMDB ID | HMDB0060616 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Tamoxifen-N-glucuronide |
|---|
| Description | Tamoxifen-N-glucuronide belongs to the class of organic compounds known as stilbene glycosides. Stilbene glycosides are compounds structurally characterized by the presence of a carbohydrate moiety glycosidically linked to the stilbene skeleton. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen-N-glucuronide is an extremely weak basic (essentially neutral) compound (based on its pKa). tamoxifen-N-glucuronide and uridine 5'-diphosphate can be biosynthesized from tamoxifen and uridine diphosphate glucuronic acid through its interaction with the enzyme UDP-glucuronosyltransferase 1-4. In humans, tamoxifen-N-glucuronide is involved in tamoxifen action pathway. Tamoxifen-N-glucuronide is a metabolite of tamoxifen. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. |
|---|
| Structure | CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)C=C1)C1=CC=CC=C1 InChI=1S/C32H37NO7/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)39-20-19-33(2,3)31-29(36)27(34)28(35)30(40-31)32(37)38/h5-18,27-31,34-36H,4,19-20H2,1-3H3/p+1/b26-25-/t27-,28-,29+,30-,31+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Tamoxifen N-glucuronide | ChEBI | | Tamoxifen N-b-D-glucosiduronate | HMDB | | Tamoxifen N-b-D-glucosiduronic acid | HMDB | | Tamoxifen N-beta-D-glucosiduronate | HMDB | | Tamoxifen N-β-D-glucosiduronate | HMDB | | Tamoxifen N-β-D-glucosiduronic acid | HMDB |
|
|---|
| Chemical Formula | C32H38NO7 |
|---|
| Average Molecular Weight | 548.6466 |
|---|
| Monoisotopic Molecular Weight | 548.264827575 |
|---|
| IUPAC Name | (2R,3R,4S,5S,6S)-6-carboxy-N-(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)-3,4,5-trihydroxy-N,N-dimethyloxan-2-aminium |
|---|
| Traditional Name | tamoxifen N-glucuronide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)C=C1)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C32H37NO7/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)39-20-19-33(2,3)31-29(36)27(34)28(35)30(40-31)32(37)38/h5-18,27-31,34-36H,4,19-20H2,1-3H3/p+1/b26-25-/t27-,28-,29+,30-,31+/m0/s1 |
|---|
| InChI Key | UKFQQYJAYUAYES-DTMHFWPESA-O |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as stilbene glycosides. Stilbene glycosides are compounds structurally characterized by the presence of a carbohydrate moiety glycosidically linked to the stilbene skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Stilbenes |
|---|
| Sub Class | Stilbene glycosides |
|---|
| Direct Parent | Stilbene glycosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Stilbene glycoside
- 1-n-glucuronide
- N-glucuronide
- Diphenylmethane
- Glucuronic acid or derivatives
- Glycosyl compound
- N-glycosyl compound
- Phenylpropane
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Beta-hydroxy acid
- Monocyclic benzene moiety
- Oxane
- Benzenoid
- Hydroxy acid
- Pyran
- Tetraalkylammonium salt
- Hemiaminal
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Ether
- Oxacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Polyol
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Organic salt
- Carbonyl group
- Alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic cation
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.66 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 16.6144 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.92 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3023.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 241.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 234.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 204.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 204.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 741.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 750.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 139.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1425.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 684.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1906.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 466.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 479.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 204.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 146.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Tamoxifen-N-glucuronide,1TMS,isomer #1 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)C=C1)C1=CC=CC=C1 | 4349.9 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,1TMS,isomer #2 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)C=C1)C1=CC=CC=C1 | 4313.0 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,1TMS,isomer #3 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4363.4 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,1TMS,isomer #4 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)C=C1)C1=CC=CC=C1 | 4351.7 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TMS,isomer #1 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)C=C1)C1=CC=CC=C1 | 4302.4 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TMS,isomer #2 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)C=C1)C1=CC=CC=C1 | 4290.3 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TMS,isomer #3 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4291.3 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TMS,isomer #4 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)C=C1)C1=CC=CC=C1 | 4267.9 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TMS,isomer #5 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4281.0 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TMS,isomer #6 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4300.0 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,3TMS,isomer #1 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)C=C1)C1=CC=CC=C1 | 4273.5 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,3TMS,isomer #2 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4270.9 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,3TMS,isomer #3 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4286.6 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,3TMS,isomer #4 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4258.1 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,4TMS,isomer #1 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=C1)C1=CC=CC=C1 | 4255.9 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,1TBDMS,isomer #1 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)C=C1)C1=CC=CC=C1 | 4510.5 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,1TBDMS,isomer #2 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=C1)C1=CC=CC=C1 | 4500.4 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,1TBDMS,isomer #3 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4544.9 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,1TBDMS,isomer #4 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)C=C1)C1=CC=CC=C1 | 4555.5 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TBDMS,isomer #1 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)C=C1)C1=CC=CC=C1 | 4641.6 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TBDMS,isomer #2 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=C1)C1=CC=CC=C1 | 4609.8 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TBDMS,isomer #3 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4610.8 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TBDMS,isomer #4 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=C1)C1=CC=CC=C1 | 4630.2 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TBDMS,isomer #5 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4598.1 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,2TBDMS,isomer #6 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4651.9 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,3TBDMS,isomer #1 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=C1)C1=CC=CC=C1 | 4751.8 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,3TBDMS,isomer #2 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4760.6 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,3TBDMS,isomer #3 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4750.0 | Semi standard non polar | 33892256 | | Tamoxifen-N-glucuronide,3TBDMS,isomer #4 | CC/C(=C(\C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=C1)C1=CC=CC=C1 | 4747.4 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-01q9-6508930000-8be611bef8cb9e527570 | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (2 TMS) - 70eV, Positive | splash10-003r-8826449000-396e4e676fdddcba09b2 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS ("Tamoxifen-N-glucuronide,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TMS_4_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tamoxifen-N-glucuronide GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tamoxifen-N-glucuronide 10V, Positive-QTOF | splash10-00dj-0129280000-338e28f8f1a53d669b09 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tamoxifen-N-glucuronide 20V, Positive-QTOF | splash10-00di-4259000000-d82cc4aa588b1dccc751 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tamoxifen-N-glucuronide 40V, Positive-QTOF | splash10-00di-4197000000-ef20e2b76844c56d747b | 2017-10-06 | Wishart Lab | View Spectrum |
|
|---|